BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹15,262 Cr | ₹14,756 Cr | ₹11,174 Cr | ₹8,184 Cr | ₹7,143 Cr |
What is the latest Revenue of BIOCON ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹15,262 Cr |
| Mar2024 | ₹14,756 Cr |
| Mar2023 | ₹11,174 Cr |
| Mar2022 | ₹8,184 Cr |
| Mar2021 | ₹7,143 Cr |
How is Revenue of BIOCON Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,262 Cr | 3.43 | |
| Mar2024 | ₹14,756 Cr | 32.05 | |
| Mar2023 | ₹11,174 Cr | 36.54 | |
| Mar2022 | ₹8,184 Cr | 14.57 | |
| Mar2021 | ₹7,143 Cr | - | |
Compare Revenue of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,048.5 Cr | -1.2% | -3.3% | 16.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.2% |
-3.3% |
16.8% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses